Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,139.83
+60.97
(+0.75%)
FTSE 250
19,824.16
+222.18
(+1.13%)
AIM
755.28
+2.16
(+0.29%)
GBP/EUR
1.1679
+0.0022
(+0.19%)
GBP/USD
1.2494
-0.0017
(-0.13%)
Bitcoin GBP
50,309.01
+403.67
(+0.81%)
BRANDS
'We sold £1.5m of product in our first week'
Lyma founder on rise of her wellness company
Cellectar Biosciences, Inc. (CLRB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0300
+0.0100
(+0.33%)
At close: 04:00PM EDT
3.1624
+0.13
(+4.37%)
After hours:
06:01PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
28,211
28,211
19,220
17,586
10,141
Selling general and administrative
10,749
10,749
9,594
6,545
5,150
Total operating expenses
38,961
38,961
28,814
24,131
15,290
Operating income or loss
-38,961
-38,961
-28,814
-24,131
-15,290
Total other income/expenses net
530
530
-
6.634
185.28
Income before tax
-38,043
-38,043
-28,661
-24,122
-15,094
Income tax expense
-60
-60
-60
0
-
Income from continuing operations
-37,983
-37,983
-28,601
-24,122
-15,094
Net income
-37,983
-37,983
-28,601
-24,122
-15,094
Net income available to common shareholders
-37,983
-37,983
-28,601
-24,122
-15,094
Basic EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Diluted EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Basic average shares
10,931
12,222
7,056
5,552
1,981
Diluted average shares
10,931
12,222
7,056
5,552
1,981
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.